UK shares: 10 big risks I see for 2021 and what I’d buy next

Manika Premsingh sees many risks to investing in UK shares right now. But she also thinks good investments can still be made in select FTSE 100 companies that can stay resilient.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

There are a lot of potential opportunities for investors in 2021. The most obvious one is the still relatively easy availability of cheap UK shares.

The risks to UK shares 

But there are plenty of risks too. Here are 10 I can think of for a start:

1. Coronavirus variants: The pandemic appears far from over as the coronavirus mutates. Will the vaccines developed continue to be effective? We don’t know.  

2. Reach of vaccines: Scepticism about vaccine effectiveness, or, worse, suspicions about their motives, may cause delays in a process that will take time any way. 

3. Brexit delays: Despite the free-trade agreement between the UK and EU, increased paperwork has created delays in getting goods to the EU. If continued, there’s no saying how much business will slow down. 

4. Currency crash can impact UK shares: I think the British pound is relatively more vulnerable after Brexit. If it shows ongoing weakness against the euro and other major currencies, inflation could rise. That wouldn’t be good news at a time of slow growth. 

5. Policy support withdrawal: Fiscal support will be withdrawn at some point, which could result in a real economic slump.

6. China slumps again: In 2020, a big lift for the world, and indeed for FTSE 100 shares, came from China’s economic bounce back. But new coronavirus cases have erupted there, indicating the need to be vigilant, still. 

7. Continued global slowdown: Forecasts for the economy offer hope, but they can be subject to change. This could be so if the corona-crisis continues or if the underlying damage to the economy turns our far greater than we can assess now. 

8. Geo-political stressors come back: Before the coronavirus took centre-stage in 2020, the US and Iran were at loggerheads. The price of oil spiked, which if continued could’ve had implications for UK shares, especially big oil. We can’t rule out the possibility of similar stressors showing up again.

9. Corporate insolvency for UK shares: With finances decimated, many companies’ debts are running up. If Covid-19 continues longer than expected, I reckon we will see more insolvencies over time, including among big UK shares. 

10. Stock market crash, 2021: These risks in turn could result in another stock market crash. Even without them, the markets themselves have run-up sharply since November, creating the risk of an overheating in UK shares’ prices.

How I’d invest now

So, should I abandon stock investing for now? 

It’s entirely possible that some of these risks don’t play out at all. But I think it’s still worthwhile to know about them. If I have them in mind, I can buy stocks that can serve me well even in tough times. 

I think there are two ways to think of such stocks:

  1. Longevity: These are companies with a history of survival. Unilever, for example, has been around since the Great Depression. So has multi-commodity miner Anglo American. I think this means they are more likely to survive another crash, if it occurs.
  2. Essentials: Healthcare is the perfect example of a sector where demand is relatively inflexible irrespective of the state of the economy. AstraZeneca and Hikma Pharmaceuticals are UK examples.

I believe these kinds of shares can benefit my portfolio over time, irrespective of the risks that exist in the near term.

Manika Premsingh owns shares of AstraZeneca. The Motley Fool UK has recommended Hikma Pharmaceuticals and Unilever. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Close-up of British bank notes
Investing Articles

£9,000 in savings? Here’s how to try and turn that into a £193 monthly second income

With a long-term approach and applying basic principles of good investment, our writer reckons someone with under £10k could earn…

Read more »

Investing Articles

A 2026 stock market crash could be a rare passive income opportunity

If a stock market crash comes our way then it might throw up plentiful opportunities for investors to secure a…

Read more »

Tesla car at super charger station
Investing Articles

£10,000 invested in Tesla stock 1 year ago is now worth…

Dr James Fox takes a closer look at Tesla stock with the incredibly volatile mega-cap company surging and pulling back…

Read more »

British pound data
Investing Articles

My personal warning for anyone tempted by the plunging Aston Martin share price

Harvey Jones was so captivated by the plunging Aston Martin share price that he ignored an old piece of investment…

Read more »

Stacks of coins
Investing Articles

This penny share just crashed 13% to 19p! Time to buy?

After another fall today, this penny stock has now crashed 70% since April 2021. Is it one that should be…

Read more »

Trader on video call from his home office
Investing Articles

Down 19%! Here’s why Barclays shares look a serious bargain to me right now

Barclays shares have slumped recently, but a big gap between price and fair value has opened, offering nimble long-term investors…

Read more »

CEO Mark Zuckerberg at F8 2019 event
Investing Articles

Why Meta Platforms shares fell 12.5% in March

Historically, investors have done well by buying Meta Platforms shares when the price has fallen. But is the latest legal…

Read more »

Arrow symbol glowing amid black arrow symbols on black background.
Investing Articles

£20,000 invested in BAE Systems shares 4 years ago is now worth…

BAE Systems' shares have soared since 2022, yet rising NATO budgets are just starting to feed through, so the real…

Read more »